Author
Listed:
- Latha Kadalayil
(University of Southampton, Southampton General Hospital
University of Southampton, Highfield Campus)
- Sofia Khan
(University of Helsinki and Helsinki University Hospital)
- Heli Nevanlinna
(University of Helsinki and Helsinki University Hospital)
- Peter A. Fasching
(University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN)
- Fergus J. Couch
(Mayo Clinic)
- John L. Hopper
(The University of Melbourne, Melbourne)
- Jianjun Liu
(Genome Institute of Singapore
National University of Singapore, 12 Science Drive 2)
- Tom Maishman
(University of Southampton and University Hospital Southampton NHS Foundation Trust)
- Lorraine Durcan
(University of Southampton and University Hospital Southampton NHS Foundation Trust)
- Sue Gerty
(University of Southampton and University Hospital Southampton NHS Foundation Trust)
- Carl Blomqvist
(Helsinki University Central Hospital)
- Brigitte Rack
(University Ulm, Prittwitzstrasse 43)
- Wolfgang Janni
(University Ulm, Prittwitzstrasse 43)
- Andrew Collins
(University of Southampton, Southampton General Hospital)
- Diana Eccles
(University of Southampton, Southampton University Hospitals NHS Trust)
- William Tapper
(University of Southampton, Southampton General Hospital)
Abstract
To identify genetic variants associated with breast cancer prognosis we conduct a meta-analysis of overall survival (OS) and disease-free survival (DFS) in 6042 patients from four cohorts. In young women, breast cancer is characterized by a higher incidence of adverse pathological features, unique gene expression profiles and worse survival, which may relate to germline variation. To explore this hypothesis, we also perform survival analysis in 2315 patients aged ≤ 40 years at diagnosis. Here, we identify two SNPs associated with early-onset DFS, rs715212 (P meta = 3.54 × 10−5) and rs10963755 (P meta = 3.91 × 10−4) in ADAMTSL1. The effect of these SNPs is independent of classical prognostic factors and there is no heterogeneity between cohorts. Most importantly, the association with rs715212 is noteworthy (FPRP
Suggested Citation
Latha Kadalayil & Sofia Khan & Heli Nevanlinna & Peter A. Fasching & Fergus J. Couch & John L. Hopper & Jianjun Liu & Tom Maishman & Lorraine Durcan & Sue Gerty & Carl Blomqvist & Brigitte Rack & Wolf, 2017.
"Germline variation in ADAMTSL1 is associated with prognosis following breast cancer treatment in young women,"
Nature Communications, Nature, vol. 8(1), pages 1-12, December.
Handle:
RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_s41467-017-01775-y
DOI: 10.1038/s41467-017-01775-y
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_s41467-017-01775-y. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.